Publique en esta revista
Información de la revista


Contenidos del congreso
XXIII Congreso Nacional de la Sociedad Española de Neurocirugía
Salamanca, 14-17 Mayo 2019
Listado de sesiones
Texto completo


R. Prat Acín1, S. Esteban Rubio2, I. Galeano Senabre1, J. Carrión Navarro3, N. García Romero4, C. Fernández Carballal5, C. Belda Iniesta6 and A. Ayuso Sacido6

1Hospital Universitario y Politécnico La Fe, Valencia, España. 2Universidad San Pablo-Ceu, Madrid, España. 3Fundación de Investigación HM Hospitales-IMMA, Madrid, España. 4IMDEA Nanoscience, Madrid, España. 5Hospital General Universitario Gregorio Marañón, Madrid, España. 6Universidad San Pablo-Ceu, Fundación de Investigación HM Hospitales-IMMA, IMDEA Nanoscience, Madrid, España.

Objectives: The identification and validation of biomarkers for prognostic and respond to therapy value, using minimally invasive approaches, along the course of the disease, will significally improve the management of these tumors. Glioma cell extracellular vesicles (EVs) containing mRNA, gDNA or proteins, can cross the Blood Brain Barrier reaching the peripheral blood, from where they can be isolated and their cargo analysed. Somatic mutations at codon 132 of the isocitrate dehydrogenase 1 gene (IDH1) have been identified in approximately 12% of glioblastomas. This subgroup of patients display better prognostic, with improved overall survival.

Methods: Human GBM cells were xenografted into athymic mice brain. After tumor growth, peripheral blood was extracted and EVs isolated. gDNA sequences within EVs were amplified with IDH1-human primers and compared to gDNA from their corresponding GBM cells.

Results: We have studied IDH1 sequence on 25 samples of paraffin embedded tissue and their respective peripheral blood samples from patients diagnosed with different degree of gliomas. We found IDH1 sequences in gDNA-EVs from all patients samples studied. Moreover, gDNA within EVs correlates with their corresponding gDNA tissue.

Conclusions: IDH1 gDNA sequence from brain tumor cells can be found in EVs isolated from peripheral blood of GBM patients. Therefore, EVs cargo could be used as a biomarker via a minimally invasive technique.


Suscríbase a la newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.